Fresenius Medical Care AG & Co. KGaA (FMS) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Care Facilities Branche. Der Hauptsitz des Unternehmens ist in Bad Homburg, Germany. Der aktuelle CEO ist Helen Giza.
FMS hat IPO-Datum 1996-09-17, 112,035 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $13.38B.
Fresenius Medical Care AG & Co. KGaA is a global leader in dialysis care and renal disease treatment, operating approximately 4,171 outpatient dialysis clinics across 150 countries. The company provides comprehensive dialysis services including treatment delivery, laboratory diagnostics, patient support, and clinical monitoring, alongside specialized services for hospitalized end-stage renal disease patients and those with acute kidney failure. It manufactures and distributes a broad portfolio of dialysis products such as dialyzers, hemodialysis machines, peritoneal dialysis solutions, and water treatment systems, as well as renal pharmaceuticals and non-dialysis products including cardiopulmonary and apheresis solutions. Additionally, the company offers vascular care, cardiovascular services, and physician nephrology and cardiology services through ambulatory surgery centers. Headquartered in Bad Homburg, Germany, Fresenius Medical Care distributes its products through direct sales channels, independent distributors, and dealers to dialysis clinics, hospitals, and specialized treatment facilities worldwide.
